by bureau Peppr | 26 April, 2021 | Campaigns
BioConnection ensures your clinical and commercial supply line for steriles, even in pandemic times Have you experienced the worldwide GMP manufacturing capacity for sterile injectables being very limited due to the high demand for Covid-19 treatments and vaccines? Do...
by bureau Peppr | 10 February, 2021 | News
With the EU and US GMP capabilities from our facility in Oss, BioConnection is proud to assist VarmX to accelerate the GMP manufacturing trajectory and bring VMX-C001 into clinical trials and ultimately to patients who currently have limited options to effective and...
by bureau Peppr | 23 December, 2020 | News
BioConnection announces that it is collaborating with AdaptVac for the Drug Product manufacture of their COVID-19 vaccine in its state-of-the-art-GMP manufacturing facility in the Netherlands. AdaptVac aims to accelerate the development of safe and efficacious...
by bureau Peppr | 22 June, 2020 | News
With our capabilities from our facility in Oss, the Netherlands, we are able to assist AIMM Therapeutics in the development of their groundbreaking clinical phase anti-cancer...
by bureau Peppr | 12 May, 2020 | News
BioConnection B.V. / Oss, The Netherlands BioConnection has sterile drug product production capacity available for COVID-19 programs BioConnection (established in 2005) is an independent CMO (Contract Manufacturing Organization). We have our own facility in Oss, The...
